Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer

doi:10.3748/wjg.v19.i21.3263

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5737)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

300

HTML

3074

Figures (1-4)

178

Tables (1-3)

184

Sum=3736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1075

Download

926

Sum=2001

Jun 7, 2013 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 7, 2013; 19(21): 3263-3271
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3263

Table 3 Tumour length (median and range in mm) and the area (median and range in mm) using magnetic resonance imaging and endosonography before and after chemotherapy in 18 patients

Modality	Before chemotherapy		After chemotherapy		Specimen
	Length	Area	Length	Area	Length
MRI	47 (36-68)	641 (283-1345)	44 (19-68)	616 (156-1431)	Not applicable
ERUS	46 (29-59)	680 (290-2110)	41 (15-56)	595 (100-1380)	Not applicable
Histopathology	Not applicable	Not applicable	Not applicable	Not applicable	34 (12-70)

MRI: Magnetic resonance imaging; ERUS: Endosonography.

Citation: Swartling T, Kälebo P, Derwinger K, Gustavsson B, Kurlberg G. Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer. World J Gastroenterol 2013; 19(21): 3263-3271
URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3263.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i21.3263